Azerbaijan vs Brazil: Cases started on MDR-TB treatment
Azerbaijan
1,026
in 2024
Brazil
843
in 2024
Azerbaijan rank
20th
Brazil rank
21st
Cases started on MDR-TB treatment over time
- Azerbaijan
- Brazil
How they compare
Azerbaijan currently reports 1,026 against 843 in Brazil, a difference of 183.
That makes Azerbaijan's figure about 1.2 times Brazil's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Brazil ahead.
Azerbaijan ranks 20th and Brazil ranks 21st of 193 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Brazil in 1.
Head to head by decade
| Decade | Azerbaijan | Brazil | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 699 | 714.2 | 15.2 | Brazil |
| 2020s | 947.4 | 762.8 | 184.6 | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Azerbaijan or Brazil?
- Azerbaijan, at 1,026 against 843 in Brazil as of 2024.
- What is the difference in cases started on mdr-tb treatment between Azerbaijan and Brazil?
- 183, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Brazil?
- 15 years are reported by both, from 2010 to 2024.
- How do Azerbaijan and Brazil rank globally for cases started on mdr-tb treatment?
- Azerbaijan ranks 20th and Brazil ranks 21st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.